Hem › T-cellslymfom › Pennsylvania
Kliniska studier för T-cellslymfom i Pennsylvania
12 studier för T-cellslymfom söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT04803201Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital of Philadelphia, Philadelphia
RekryterarObservationsstudie
Ålder 0 till 38 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06131801Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
- University of Pittsburgh Medical Center, Pittsburgh
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06561048BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT04752826Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 14 sep. 2026 · NCT06724237A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT04104776CD45BE-HSPC + CART-45 Cells
- University of Pennsylvania, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 10 aug. 2026 · NCT07451054Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1
Ålder 0 till 29 · Alla kön · Uppdaterad 7 juli 2026 · NCT06934382A Registry for People With T-cell Lymphoma
- University of Pennsylvania (Data Collection Only), Philadelphia
- Thomas Jefferson University Hospital (Data collection only), Philadelphia
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 20 maj 2026 · NCT05978141CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
- University of Pennsylvania - Abramson Caner Center, Philadelphia
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 10 nov. 2025 · NCT06420089Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2025 · NCT04234048Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1
Ålder 1 till 21 · Alla kön · Uppdaterad 6 dec. 2024 · NCT05476770Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.